Combining structural brain changes improves the prediction of Alzheimer's disease and mild cognitive impairment

Dementia and Geriatric Cognitive Disorders

Volumn 33, Issue 5, 2012, Pages 318-326

  Zhang, Ningnannan ^a,c   Song, Xiaowei ^a,b   Zhang, Yunting ^c  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Aging; Alzheimer's disease; Brain atrophy and lesion index; Medial temporal lobe atrophy scale; Mild cognitive impairment; Structural magnetic resonance imaging

Indexed keywords

ACCURACY; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIAL TEMPORAL LOBE ATROPHY; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ATROPHY; BRAIN; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TEMPORAL LOBE;

EID: 84863095199     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000339364     Document Type: Article

References (51)

1. Duara R, Loewenstein DA, Potter E, Appel J, Greig MT, Urs R, Shen Q, Raj A, Small B, Barker W, Schofield E, Wu Y, Potter H: Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology 2008;71:1986-1992
2. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P: Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734-746
3. Galluzzi S, Talassi E, Belussi M, Scheltens P, van de Pol L, Nobili F, Rodriguez G, Froelich L, Damian M, Martinez-Lage P, Gomez-Isla T, Reynish E, Ousset PJ, Vellas B, Frisoni GB: Multi-center comparison of medial temporal atrophy in patients with Alzheimer's disease - Data from the ICTUS study. Dement Geriatr Cogn Disord 2008;26:314-322
4. Korf ES, Wahlund LO, Visser PJ, Scheltens P. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004;63:94-100
5. Geroldi C, Rossi R, Calvagna C, Testa C, Bresciani L, Binetti G, Zanetti O, Frosoni GB: Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment. J Neurol Neurosurg Psychiatry 2006;77: 1219-1222
6. Prasad K, Wiryasaputra L, Ng A, Kandiah N: White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort. Dement Geriatr Cogn Disord 2011;31:431-434
7. Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, Niessen WJ, Breteler MM, Van Der Lugt A: Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821-1828
8. Schneider JA, Boyle PA, Arvanitakis Z, Bienias JL, Bennett DA: Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol 2007; 62:59-66
9. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM: Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004;61:1531-1534
10. Sinka L, Kovari E, Gold G, Hof PR, Herrmann FR, Bouras C, Giannakopoulos P: Small vascular and Alzheimer disease-related pathologic determinants of dementia in the oldest-old. J Neuropathol Exp Neurol 2010; 69:1247-1255
11. Silbert LC, Howieson DB, Dodge H, Kaye JA: Cognitive impairment risk: White matter hyperintensity progression matters. Neurology 2009;73:120-125
12. Stenset V, Hofoss D, Berstad AE, Negaard A, Gjerstad L, Fladby T: White matter lesion subtypes and cognitive deficits in patients with memory impairment. Dement Geriatr Cogn Disord 2008;26:424-431
13. Agosta F, Pievani M, Sala S, Geroldi C, Galluzzi S, Frisoni GB, Filippi M: White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology 2011; 258:853-863
14. Eckerstrom C, Olsson E, Klasson N, Bjerke M, Gothlin M, Jonsson M, Rolstad S, Malmgren H, Wallin A, Edman A: High white matter lesion load is ssociated with hippocampal atrophy in mild cognitive impairment. Dement Geriatr Cogn Disord 2011; 31:132-138
15. de Leeuw FE, Korf E, Barkhof F, Scheltens P: White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease. Stroke 2006;37: 2248-2252
16. Raji CA, Lopez OL, Kuller LH, Carmichael OT, Longstreth WT Jr, Gach HM, Boardman J, Bernick CB, Thompson PM, Becker JT: White matter lesions and brain gray matter volume in cognitively normal elders. Neurobiol Aging 2012;33:834.e7-834.e16
17. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C, Medical Research Council Cognitive Function and Ageing Study: Age, neuropathology, and dementia. N Engl J Med 2009;360:2302-2309
18. Launer LJ, Hughes TM, White LR: Microinfarcts, brain atrophy, and cognitive function: The Honolulu Asia Aging Study Autopsy Study. Ann Neurol 2011;70:774-780
19. Chowdhury MH, Nagai A, Bokura H, Nakamura E, Kobayashi S, Yamaguchi S: Agerelated changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors. J Stroke Cerebrovasc Dis 2011;20:302-309
20. Shim YS, Youn YC, Na DL, Kim SY, Cheong HK, Moon SY, Park KW, Ku BD, Lee JY, Jeong JH, Kang H, Kim EJ, Lee JS, Go SM, Kim SH, Cha KR, Seo SW: Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease. Eur Neurol 2011; 66:75-82
21. Chen W, Song X, Zhang Y, Darvesh S, Zhang N, D'Arcy RC, Black S, Rockwood K: An MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimer's disease, mild cognitive impairment and normal aging. Dement Geriatr Cogn Disord 2010;30:121-130
22. Zhang N, Song X, Zhang Y, Chen W, D'Arcy RC, Darvesh S, Fisk JD, Rockwood K, Alzheimer's disease Neuroimaging Initiative: An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: A follow-up study. J Alzheimers Dis 2011;26(suppl 3): 359-367
23. Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, Shaw L Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M, Alzheimer's Disease Neuroimaging Initiative: The Alzheimer's disease neuroimaging initiative: Progress report and future plans. Alzheimers Dement 2010;6:201-211.e7
24. Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, L Whitwell J, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW: The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 2008;27:685-691
25. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J: Atrophy of medial temporal lobes on MRI in 'probable' Alzheimer's disease and normal ageing: Diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55:967-972
26. Barber R, Ballard C, McKeith IG, Gholkar A, O'Brien JT: MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia. Neurology 2008; 54:1304-1309
27. Burton EJ, Barber R, Mukaetova-Ladinska EB, Robson J, Perry RH, Jaros E, Kalaria RN, O'Brien JT: Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: A prospective study with pathological verification of diagnosis. Brain 2009;132:195-203
28. Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J: Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 2002;72:491-497
29. Convit A, de Asis J, de Leon MJ, Tarshish CY, De Santi S, Rusinek H: Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to lzheimer's disease. Neurobiol Aging 2000;21:19-26
30. Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS: Mri measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 2002;58:1188-1196
31. Tondelli M, Wilcock GK, Nichelli P, De Jager CA, Jenkinson M, Zamboni G: Structural MRI changes detectable up to ten years before clinical Alzheimer's disease. Neurobiol Aging 2012;33:e25-e36
32. Westman E, Cavallin L, Muehlboeck JS, Zhang Y, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Spenger C, Lovestone S, Simmons A, Wahlund LO, AddNeuroMed consortium. Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS One 2011;6:e22506
33. Fox NC, Freeborough PA, Rossor MN: Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet 1996;348: 94-97
34. Shen Q, Loewenstein DA, Potter E, Zhao W, Appel J, Greig MT, Raj A, Acevedo A, Schofield E, Barker W, Wu Y, Potter H, Duara R: Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease. Alzheimers Dement 2011; 7:e101-e108
35. Waldemar G: Visual rating and ROI-based parametric analysis of rCBF SPECT in patients with mild or questionable dementia: A comparative study. Dement Geriatr Cogn Disord 2007;24:429-433
36. DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC, Thal LJ, Jin S, Jack CR Jr, Scheltens P, Alzheimer's Disease Cooperative Study Group: Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol 2007; 64:108-115
37. Dickerson BC, Stoub TR, Shah RC, Sperling RA, Killiany RJ, Albert MS, Hyman BT, Blacker D, Detoledo-Morrell L: Alzheimer- signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 2011;76:1395-1402
38. van Straaten EC, Harvey D, Scheltens P, Barkhof F, Petersen RC, Thal LJ, Jack CR Jr, DeCarli C, Alzheimer's Disease Cooperative Study Group: Periventricular white matter hyperintensities increase the likelihood of progression from mnestic mild cognitive impairment to dementia. J Neurol 2008;255: 1302-1308
39. Chen W, Song X, Zhang Y, for the Alzheimer's Disease Neuroimaging Initiative: Assessment of the Virchow-Robin spaces in Alzheimer's disease, mild cognitive impairment, and normal aging, using high-field MRI. AJNR Am J Neuroradiol 2011;32:1490-1495
40. Gold G, Kovari E, Herrmann FR, Canuto A, Hof PR, Michel JP, Bouras C, Giannakopoulos P: Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke 2005; 36:1184-1188
41. Carmichael O, Schwarz C, Drucker D, Fletcher E, Harvey D, Beckett L, Jack CR, Weiner M, DeCarli C, Alzheimer's Disease Neuroimaging Initiative: Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol 2010; 67:1370-1378
42. Schmidt R, Ropele S, Enzinger C, Petrovic K, Smith S, Schmidt H, Matthews PM, Fazekas F: White matter lesion progression, brain atrophy, and cognitive decline: The Austrian stroke prevention study. Ann Neurol 2005; 58:610-616
43. Blum S, Luchsinger JA, Manly JJ, Schupf N, Stern Y, Brown TR, DeCarli C, Small SA, Mayeux R, Brickman AM: Memory after silent stroke: Hippocampus and infarcts both matter. Neurology 2012;78:38-46
44. Rossi R, Geroldi C, Bresciani L, Testa C, Binetti G, Zanetti O, Frisoni GB: Clinical and neuropsychological features associated with structural imaging patterns in patients with mild cognitive impairment. Dement Geriatr Cogn Disord 2007;23:175-183
45. Appel J, Potter E, Bhatia N, Shen Q, Zhao W, Greig MT, Raj A, Barker WW, Potter H, Schofield E, Wu Y, Loewenstein DA, Duara R: Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors. AJNR Am J Neuroradiol 2009;30:1870-1876
46. Jacobs HI, Van Boxtel MP, Van Der Elst W, Burgmans S, Smeets F, Gronenschild EH, Verhey FR, Uylings HB, Jolles J: Increasing the diagnostic accuracy of medial temporal lobe atrophy in Alzheimer's disease. J Alzheimers Dis 011;25:477-490
47. Brickman AM, Honig LS, Scarmeas N, Tatarina O, Sanders L, Albert MS, Brandt J, Blacker D, Stern Y: Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol 2008;65: 1202-1208
48. de la Torre JC: Vascular risk factor detection and control may prevent Alzheimer's disease. Ageing Res Rev 2010;9:218-225
49. Gouw AA, Van Der Flier WM, van Straaten EC, et al: Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis 2008;25:247-253
50. Gao FQ, Swartz RH, Scheltens P, et al: Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study. J Alzheimers Dis 2011;26: 379-388
51. Song X, Mitnitski A, Cox J, Rockwood K: Comparison of machine learning techniques with classical statistical models in predicting health outcomes. Stud Health Technol Inform 2004;107:736-740